Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q3 FY16
Take Solutions Ltd (TAKE) is currently trading at 48.89 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Take Solutions Limited is primarily focused on delivering domain-intensive services in Life Sciences, Software, and Information Technology, providing clinical, regulatory, and safety services for clients, including biopharmaceutical and generics manufacturers. The company leveraged its technology expertise to launch OneClinical, an eClinical platform that optimizes clinical trials by providing real-time data analytics and visualization, enhancing compliance and operational efficiency across industry verticals. In FY2019, Take Solutions made significant acquisitions in the U.S., including KAI Holdings Inc and Dataceutics Holdings Inc, indicating a strategic push towards expanding its footprint in scientific research and development. Take Solutions disposed of its supply chain unit in Austin, USA, indicating a strategic shift away from traditional supply chain management to focus more on the Life Sciences domain and scientific research initiatives.
Over the past 52 weeks, Take Solutions Ltd has traded between a low of ₹7.30 and a high of ₹49.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Take Solutions Ltd has a market capitalization of approximately 723.25. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Take Solutions Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 382.18 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 723.25 Cr, Take Solutions Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Take Solutions Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Take Solutions Ltd is 382.18. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Take Solutions Limited is primarily focused on delivering domain-intensive services in Life Sciences, Software, and Information Technology, providing clinical, regulatory, and safety services for clients, including biopharmaceutical and generics manufacturers.
The company leveraged its technology expertise to launch OneClinical, an eClinical platform that optimizes clinical trials by providing real-time data analytics and visualization, enhancing compliance and operational efficiency across industry verticals.
In FY2019, Take Solutions made significant acquisitions in the U.S., including KAI Holdings Inc and Dataceutics Holdings Inc, indicating a strategic push towards expanding its footprint in scientific research and development.
Take Solutions disposed of its supply chain unit in Austin, USA, indicating a strategic shift away from traditional supply chain management to focus more on the Life Sciences domain and scientific research initiatives.
Healthcare Services
Healthcare Research, Analytics & Technology
723 Cr
Low Risk
382.2
56.4
2.9
28.0
49.90
7.30
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
4
Neutral
5
Bullish
5
Bearish
8
Neutral
5
Bullish
33
Bearish
4
Neutral
0
Bullish
28
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
42.04 | 723 Cr | 382.18 | 28.03 | 0.00 | 15.55 | 21.32 | 4.57 | ||
64.02 | 160 Cr | -89.70 | 2.51 | 0.00 | -9.29 | -5.26 | -2.47 | ||
57.69 | 144 Cr | -11.80 | 0.32 | 0.00 | -2.81 | 0.93 | -2.96 | ||
17.03 | 70 Cr | 47.31 | 1.30 | 0.00 | 1.03 | 3.26 | 0.36 | ||
50.29 | 59 Cr | -58.70 | 3.24 | 0.00 | -30.18 | -32.45 | -30.18 | ||
16.98 | 22 Cr | 11.87 | 1.44 | 0.00 | 0.00 | 0.00 | 2.57 | ||
15.15 | 13 Cr | -2.00 | 0.90 | 0.00 | -23.51 | -15.08 | -7.97 | ||
| Median: 7 Co. | — | 42.04 | 70 Cr | -2.00 | 1.44 | 0.00 | -2.81 | 0.00 | -2.47 |
